Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis

Background: Adequate management of diabetes in patients with liver cirrhosis can be challenging. We conducted this study to investigate the liver-related long term outcomes of alpha-glucosidase inhibitors (AGIs) in patients with diabetes and cirrhosis. Methods: From National Health Insurance Researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Fu-Shun, Hou, Ming-Chih, Wei, James Cheng-Chung, Shih, Ying-Hsiu, Hsu, Chung Y., Hsu, Chih-Cheng, Hwu, Chii-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812564/
https://www.ncbi.nlm.nih.gov/pubmed/36618937
http://dx.doi.org/10.3389/fphar.2022.1049094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812564/
https://www.ncbi.nlm.nih.gov/pubmed/36618937
http://dx.doi.org/10.3389/fphar.2022.1049094

Ejemplares similares